Orange Book product · Brand (NDA)
VANCENASE
BECLOMETHASONE DIPROPIONATE
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
BECLOMETHASONE DIPROPIONATE
Strength
0.042MG/INH
Dosage form
AEROSOL, METERED
Route
NASAL
TE code
Not listed
Application
NDA 018521
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 2017QVAR REDIHALERBrand (NDA)
NDA 207921 · NORTON WATERFORD
- 2014QNASLBrand (NDA)
NDA 202813 · TEVA BRANDED PHARM
- 2000QVAR 40Brand (NDA)
NDA 020911 · TEVA BRANDED PHARM
- 1996VANCERIL DOUBLE STRENGTHBrand (NDA)
NDA 020486 · SCHERING
- —BECLOVENTBrand (NDA)
NDA 018153 · GLAXOSMITHKLINE
- —VANCERILBrand (NDA)
NDA 017573 · SCHERING
- —BECONASEBrand (NDA)
NDA 018584 · GLAXOSMITHKLINE
- 2025BECLOMETHASONE DIPROPIONATEGeneric (ANDA)
ANDA 213811 · AMNEAL IRELAND LTD
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
